Study of Erythropoietin (EPO) Administration Schedule
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the hemoglobin and hematocrit variability between
once and three times weekly erythropoietin therapy for the anemia in patients with
maintenance dialysis.